Cargando…
Author Correction: Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy
Autores principales: | Moretti, Federico A., Giardino, Giuliana, Attenborough, Teresa C. H., Gkazi, Athina Soragia, Margetts, Ben K., la Marca, Giancarlo, Fairbanks, Lynette, Crompton, Tessa, Gaspar, H. Bobby |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674291/ https://www.ncbi.nlm.nih.gov/pubmed/34912004 http://dx.doi.org/10.1038/s41598-021-03903-7 |
Ejemplares similares
-
Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy
por: Moretti, Federico A., et al.
Publicado: (2021) -
Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID)
por: Booth, Claire, et al.
Publicado: (2009) -
Maternal T-cell engraftment impedes with diagnosis of a SCID-ADA patient
por: Lanfranchi, Arnalda, et al.
Publicado: (2018) -
Evaluation of clonal hematopoiesis in pediatric ADA-SCID gene therapy participants
por: White, Shanna L., et al.
Publicado: (2022) -
Clinical T Cell Receptor Repertoire Deep Sequencing and Analysis: An Application to Monitor Immune Reconstitution Following Cord Blood Transplantation
por: Gkazi, Athina Soragia, et al.
Publicado: (2018)